Phys Vivas · neurological
Neurocutaneous Syndromes — Viva Defence
DCE viva defence for Neurocutaneous Syndromes.
On this page & tools
Target exams
Neurocutaneous Syndromes Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Neurocutaneous Syndromes. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Zhang S, Yang G Neurofibromin in bone disease: Mechanisms and therapeutic implications (Review) Int J Mol Med, 2026.PMID 42464674
- [2]Calonge Q, Hanin A, Dade M, Bailly L, et al. Epilepsy and disability in adults with tuberous sclerosis complex: a 16-year retrospective analysis J Neurol, 2026.PMID 42458074
- [3]Zeppieri M, D'Esposito F, Gagliano C, Battista M, et al. Looking at Optic Nerve Sheath Meningiomas Through Genetics-From Clinic to Bench and Back Again Front Biosci (Schol Ed), 2026.PMID 42411653
- [4]Erdem S, Amparore D, Re C, Verep S, et al. What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group World J Urol, 2026.PMID 42373875
- [5]Pawlak KM, Jagielski M, Papanikolaou IS, Hong W, et al. Pancreatic cystic lesions in hereditary syndromes: Diagnostic role of endoscopic ultrasound Best Pract Res Clin Gastroenterol, 2026.PMID 42167859
- [6]Miranda M, Ferreira C, Fernandes M, Lopes F, et al. Hereditary renal cell carcinoma surveillance protocols: a review of the literature and proposed recommendations Fam Cancer, 2026.PMID 41518461
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922